🟠 The #FDA issued a warning letter to Sanofi on January 15, 2025, citing significant deviations from Current Good Manufacturing Practice at its Genzyme plant in Framingham, Massachusetts.
#biotech #pharma @FDA $NVO $ALUR $SNY $SAN
#FDA #biotech #pharma #NVO #ALUR #SNY #SAN